Page 31 - Revista Argentina de Transfusión 2-2019

Declaración de conflicto de intereses 11. Rudra A, Chatterjee S, Sengupta S, Wankhede R, Nandi B, Maitra
G, Mitra J: Management of obstetric hemorrhage. Middle East
La autora ha declarado que no existe ningún conflicto J Anesthesiol 2010, 20(4):499-507.
de intereses. 12. Saad A, Costantine MM. Obstetric hemorrhage: Recent ad-
vances. Clin Obstet Gynecol. 2014;57:791—6
13. Guasch E1, Gilsanz F. Massive obstetric hemorrhage: Current
Referencias approach to management. Med Intensiva. 2016 Jun-Jul;
40(5):298-310.
1. WHO. WHO recommendations for the prevention and treat- 14. Natascha de Lange, Pim Schol, Marcus Lance, Mallory Woiski,
ment of postpartum haemorrhage. Geneva: World Health Or- Josje Langenveld, Robbert Rijnders, et al. Restrictive Versus
ganization, 2012. Massive Fluid Resuscitation Strategy (REFILL study), influence
2. Kozek-Langenecker SA, Afshari A, Albaladejo P, Aldecoa- on blood loss and hemostatic parameters in obstetric
Santullano CA, De robertis E, Filipescu DC, et al. Management hemorrhage: study protocol for a randomized controlled trial.
of severe perioperative bleeding: Guidelines from the Euro- Published online 2018 Mar 6. https://doi.org/10.1186/s13063-
pean Society of Anaesthesiology. Eur J Anaesthesiol. 2013; 018-2512-z.
30:270—382. 15. Dilla AJ, Waters JH, Yazer MH. Clinical validation of risk strati-
3. Lockhart E. Postpartum hemorrhage: a continuing challenge. fication criteria for peripartum hemorrhage. Obstet Gynecol.
Hematology Am Soc Hematol Educ Program. 2015; 2015:132- 2013; 122:120-6.
7. 16. Butwick AJ, Goodnough LT. Transfusion and coagulation man-
4. Dra. Patricia Asturizaga, Dra. Lilian Toledo Jaldin. Hemorragia agement in major obstetric hemorrhage. Curr Opin Anesthesiol.
Obstetrica. Rev Med La Paz, 20(2); Julio - Diciembre 2014; 57- 2015; 28:275-84.
68. 17. Davies T, Catling S, Grainger H. Intraoperative cell salvage in
5. Ministerio de Salud de la Provincia de Buenos Aires. Mayo obstetric by Hannah Grainger and Sue Catling. J Perioper Pract.
2017. www.ms.gba.gov.ar/sitios/cadavidacuenta/files/2017/ 2011 Dec; 21(12):400.
informe-MM-2017.pd 18. Haas T, Fries D, Tanaka KA, et al. Usefulness of standard plasma
6. Dr. Angel Augusto Perez-Calatayud, Acad. Dr. Raul Carrillo-Esper, coagulation tests in the management of perioperative
Dr. Jesus Carlos Briones-Garduno. Protocolo de actuacion para coagulopathic bleeding: is there any evidence? Br J Anaesth.
el manejo de la hemorragia crítica obstétrica. Rev. Mexicana 2015; 114:217–224.
de Anestesiología. Vol 40. Supl 2. Julio-Septiembre 2017; 416- 19. Ducloy-Bouthors AS, Duhamel A, Kipnis E, Tournoys A, Prado-
419. Dupont A, Elkalioubie A, et al. Postpartum haemorrhage re-
7. Alejandra Debonis. Sangrado en obstetricia. Rev. Sociedad Ar- lated early increase in Ddimers is inhibited by tranexamic acid:
gentina de Hematologia. Vol 16. 2012; 21-24 haemostasis parameters of a randomized controlled open la-
8. Lier H, von Heymann C, Korte W, Schlembach D. Peripartum belled trial. Br J Anaesth 2016;116:641–648
Haemorrhage: Haemostatic Aspect of the New German PPH 20. Shakur H, Elbourne D, Gulmezoglu M, Alfi revic Z, Ronsmans C,
Guideline. Transfus Med Hemother. 2018 Apr; 45(2):127-135. Allen E, et al. The WOMAN Trial (World Maternal Antifi brinolytic
9. Mousa HA1, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z Trial): tranexamic acid for the treatment of postpartum haem-
Mousa HA, Alfirevic Z: Treatment for primary postpartum haem- orrhage: an international randomized, double blind placebo con-
orrhage. Cochrane Database Syst Rev 2007(1):CD003249. trolled trial. Trials. 2010; 11:40.
10. Abdul-Kadir R, McLintock C, Ducloy AS, et al. Evaluation and
management of postpartum hemorrhage: consensus from an
international expert panel. Transfusion. 2014; 54(7):1756-1768.

Curso AAHITC de Médico Especialista en Hemoterapia Vol. XLV / N° 2 / 2019 Asociación Argentina Pág. 115
e Inmunohematología. Formación en Medicina Págs. 107 / 115 de Hemoterapia,
Transfusional y Terapia Celular. Inmunohematología
Manejo de sangrado obstétrico. y Terapia Celular